Acromegaly Treatment Quality of Life Study

Completed

Conditions studied: Acromegaly

In brief

The investigators hypothesize that treatment of acromegaly will be associated with an improvement in quality of life compared to active acromegaly. At the same time, they will also be studying the effects of different acromegaly treatments on the quality of life.

Key facts

Study ID

NCT01732406

Run by

Massachusetts General Hospital

People needed

126

Starts

2013-01-01

Expected to finish

2016-12-19

Last updated by the study team

2019-04-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-90
• Active acromegaly or receiving pegvisomant monotherapy or receiving somatostatin analog monotherapy

You may not qualify if…

• Untreated thyroid or adrenal insufficiency. Subjects on replacement therapy must be stable for at least 3 months prior to entry into the study
• Initiation or discontinuation of testosterone or estrogen within 3 months of entry
• Pregnant and nursing women

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.